1. Novel 4-methoxynaphthalene- N -acylhydrazones as potential for paracoccidioidomycosis and tuberculosis co-infection.
- Author
-
Rozada AM, Rodrigues FA, Sampiron EG, Seixas FA, Basso EA, Scodro RB, Kioshima ÉS, and Gauze GF
- Subjects
- Amphotericin B pharmacology, Anti-Bacterial Agents chemical synthesis, Antifungal Agents chemical synthesis, Drug Combinations, Drug Discovery, Drug Synergism, Ethambutol pharmacology, Humans, Microbial Sensitivity Tests, Mycobacterium tuberculosis pathogenicity, Paracoccidioides pathogenicity, Anti-Bacterial Agents pharmacology, Antifungal Agents pharmacology, Coinfection drug therapy, Mycobacterium tuberculosis drug effects, Paracoccidioides drug effects, Paracoccidioidomycosis drug therapy, Tuberculosis drug therapy
- Abstract
Aim: 17 new 4-methoxynaphthalene- N -acylhydrazones were synthesized in order to evaluate their biological action against important pathogens. Methods: In vitro susceptibility assays of compounds were performed against Paracoccidioides brasiliensis and Mycobacterium tuberculosis . Results: Compounds 4a , 4b and 4k were the most potent against P. brasiliensis , two with minimum inhibitory concentrations of ≤1 μg ml
-1 and exhibited pharmacological synergy with amphotericin B. The compounds also showed activity against M. tuberculosis , with 4c and 4k being the more promising. Compound 4k showed good synergistic antimycobacterium activity with ethambutol. None of the compounds tested showed toxicity. Conclusion: We highlight the compound 4k , as a potential agent for the treatment of patients co-infected with paracoccidioidomycosis and tuberculosis.- Published
- 2019
- Full Text
- View/download PDF